Gene · 2823
Papers1,924
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,924
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ALKBH5 Protects Against Hepatic Ischemia-Reperfusion Injury by Regulating YTHDF1-Mediated YAP Expression. | Int J Mol Sci | 2024 | 39519091 | PubTator, text mining | PubMed |
| Insights into the Mode and Mechanism of Interactions Between RNA and RNA-Binding Proteins. | Int J Mol Sci | 2024 | 39518890 | PubTator, text mining | PubMed |
| RNA dynamics in oxidative stress: From obscurity to mechanistic understanding in health and disease. | Proc Natl Acad Sci U S A | 2024 | 39495921 | PubTator, text mining | PubMed |
| Dynamic multilayered control of m6A RNA demethylase activity. | Proc Natl Acad Sci U S A | 2024 | 39495907 | PubTator, text mining | PubMed |
| Development and validation of a 6-gene signature derived from RNA modification-associated genes for the diagnosis of Acute Stanford Type A Aortic Dissection. | J Geriatr Cardiol | 2024 | 39483269 | PubTator, text mining | PubMed |
| iDNA-ITLM: An interpretable and transferable learning model for identifying DNA methylation. | PLoS One | 2024 | 39480834 | PubTator, text mining | PubMed |
| RNA methylation patterns of tumor microenvironment cells regulate prognosis and immunotherapeutic responsiveness in patients with triple-negative breast cancer. | Sci Rep | 2024 | 39478153 | PubTator, text mining | PubMed |
| N6-Methyladenosine methylation modification in breast cancer: current insights. | J Transl Med | 2024 | 39468547 | PubTator, text mining | PubMed |
| Cap-Specific m6Am Methyltransferase PCIF1/CAPAM Regulates mRNA Stability of RAB23 and CNOT6 through the m6A Methyltransferase Activity. | Cells | 2024 | 39451207 | PubTator, text mining | PubMed |
| FTO in oral diseases: Functions, mechanisms, and therapeutic potential. | FASEB J | 2024 | 39436191 | PubTator, text mining | PubMed |
| The m5C/m6A/m7G-related non-apoptotic regulatory cell death genes for the prediction of the prognosis and immune infiltration status in hepatocellular carcinoma. | Transl Cancer Res | 2024 | 39430855 | PubTator, text mining | PubMed |
| Lactylation of RNA m6A demethylase ALKBH5 promotes innate immune response to DNA herpesviruses and mpox virus. | Proc Natl Acad Sci U S A | 2024 | 39413129 | PubTator, text mining | PubMed |
| β-Cyclodextrin-Modified Laser-Induced Graphene Electrode for Detection of N6-Methyladenosine in RNA. | Molecules | 2024 | 39407646 | PubTator, text mining | PubMed |
| RBM15 drives the progression of lung adenocarcinoma by regulating N6-methyladenosine-mediated LDHA mRNA stability. | Life Sci | 2024 | 39406308 | PubTator, text mining | PubMed |
| M6A Modification and Transcription Analysis of LncRNA in Cerebral Ischemia/Reperfusion Injury. | Int J Genomics | 2024 | 39397896 | PubTator, text mining | PubMed |
| FTO/m6A mediates miR-138-5p maturation and regulates gefitinib resistance of lung adenocarcinoma cells by miR-138-5p/LCN2 axis. | BMC Cancer | 2024 | 39394098 | PubTator, text mining | PubMed |
| FTO/IGF2BP2-mediated N6 methyladenosine modification in invasion and metastasis of thyroid carcinoma via CDH12. | Cell Death Dis | 2024 | 39379360 | PubTator, text mining | PubMed |
| IGFBP7 regulates cell proliferation and migration through JAK/STAT pathway in gastric cancer and is regulated by DNA and RNA methylation. | J Cell Mol Med | 2024 | 39351597 | PubTator, text mining | PubMed |
| Comprehensive analysis of the m6A demethylase FTO in endothelial dysfunction by MeRIP sequencing. | Exp Cell Res | 2024 | 39343042 | PubTator, text mining | PubMed |
| Prion-like Proteins in Plants: Key Regulators of Development and Environmental Adaptation via Phase Separation. | Plants (Basel) | 2024 | 39339640 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2823/papers?page=9